Bioequivalence Trials , Intersection-Union Tests , andEquivalence Con dence

[1]  D. Hauschke,et al.  Sample size determination for bioequivalence assessment by means of confidence intervals. , 1992, International journal of clinical pharmacology, therapy, and toxicology.

[2]  E. C. Fieller.  The Biological Standardization of Insulin , 1940 .

[3]  Shoichi Sasabuchi,et al.  A test of a multivariate normal mean with composite hypotheses determined by linear inequalities , 1980 .

[4]  H. I. Patel,et al.  A problem of equivalence in clinical trials , 1984 .

[5]  Stephen J. Ruberg,et al.  Multiple comparison procedures for pooling batches in stability studies , 1992 .

[6]  Anthony J. Hayter,et al.  On the Relationship between Stepwise Decision Procedures and Confidence Sets , 1994 .

[7]  D. Mandallaz,et al.  Comparison of different methods for decision-making in bioequivalence assessment. , 1981, Biometrics.

[8]  A. Munk.  An improvement of commonly used tests in bioequivalence assessment , 1993 .

[9]  G. Casella,et al.  Statistical Inference , 2003, Encyclopedia of Social Network Analysis and Mining.

[10]  Eve Bofinger.  Expanded confidence intervals, one-sided tests, and equivalence testing. , 1992, Journal of biopharmaceutical statistics.

[11]  David M. Rocke.  On testing for bioequivalence. , 1984, Biometrics.

[12]  E. C. Fieller.  SOME PROBLEMS IN INTERVAL ESTIMATION , 1954 .

[13]  Walter W. Hauck,et al.  A new procedure for testing equivalence in comparative bioavailability and other clinical trials , 1983 .

[14]  J. Liu,et al.  Bias of two one-sided tests procedures in assessment of bioequivalence. , 1995, Statistics in Medicine.

[15]  Roger L. Berger,et al.  Multiparameter Hypothesis Testing and Acceptance Sampling , 1982 .

[16]  Donald J. Schuirmann.  A comparison of the Two One-Sided Tests Procedure and the Power Approach for assessing the equivalence of average bioavailability , 1987, Journal of Pharmacokinetics and Biopharmaceutics.

[17]  Terry Hyslop,et al.  Statistical and Regulatory Considerations for Multiple Measures in Bioequivalence Testing , 1995 .

[18]  Walter W. Hauck,et al.  Consideration of individual bioequivalence , 1990, Journal of Pharmacokinetics and Biopharmaceutics.

[19]  W. Westlake,et al.  Symmetrical confidence intervals for bioequivalence trials. , 1976, Biometrics.

[20]  J. Müller-Cohrs.  An Improvement of the Westlake Symmetric Confidence Interval , 1991 .

[21]  Charles Locke.  An exact confidence interval from untransformed data for the ratio of two formulation means , 1984, Journal of Pharmacokinetics and Biopharmaceutics.

[22]  Roger L. Berger,et al.  Uniformly More Powerful Tests for Hypotheses concerning Linear Inequalities and Normal Means , 1989 .

[23]  D Hauschke,et al.  A distribution-free procedure for the statistical analysis of bioequivalence studies. , 1990, International journal of clinical pharmacology, therapy, and toxicology.

[24]  L. Brown,et al.  An unbiased test for the bioequivalence problem , 1997 .

[25]  C. Metzler.  Sample sizes for bioequivalence studies. , 1991, Statistics in medicine.

[26]  R. Berger,et al.  Uniformly More Powerful, One-sided Tests for Hypotheses about linear Inequalities , 1995 .

[27]  S. Hammill.  Correspondence with the Editor , 2005 .

[28]  R Schall,et al.  On population and individual bioequivalence. , 1993, Statistics in medicine.

[29]  A. Kinsella.  Bootstrapping a bioequivalence measure , 1989 .

[30]  S. Chow,et al.  On the assessment of variability in bioavailability/bioequivalence studies , 1992 .

[31]  Bioequivalence revisited. , 1992, Statistics in medicine.

[32]  J. Pratt.  Length of Confidence Intervals , 1961 .

[33]  L. Brown,et al.  Optimal Confidence Sets, Bioequivalence, and the Limaçon of Pascal , 1995 .

[34]  A. Rossier.  Letter to the Editor , 1986, Paraplegia.

[35]  K. F. Yee.  The calculation of probabilities in rejecting bioequivalence. , 1986, Biometrics.

[36]  Jason C. Hsu,et al.  On Confidence Sets in Multiple Comparisons , 1988 .

[37]  Syoichi Sasabuchi,et al.  A multivariate one-sided test with composite hypotheses when the covariance matrix is completely unknown , 1988 .

[38]  S. Sasabuchi.  A multivariate test with composite hypotheses determined by linear inequalities when the covariance matrix has an unknown scale factor , 1988 .

[39]  W. Hauck,et al.  Types of bioequivalence and related statistical considerations. , 1992, International journal of clinical pharmacology, therapy, and toxicology.

[40]  S. Chow,et al.  An Alternative Approach for the Assessment of Bioequivalence Between Two Formulations of a Drug , 2007 .

[41]  J C Juskevich,et al.  Bovine growth hormone: human food safety evaluation. , 1990, Science.